8-K - Medpace Holdings, Inc. - 2.02 / 5.02 / 9.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001668397-26-000017
Filing Date: 2026-04-22
Accepted: 2026-04-22 16:15:52
Documents: 13
Period of Report: 2026-04-21
Items: Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Medpace Holdings, Inc. (Filer) CIK : 0001668397 (see all company filings) EIN. : 320434904 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37856 | Film No.: 26883987 SIC : 8731 Services-Commercial Physical & Biological Research (CF Office: 08 Industrial Applications and Services)
1 | 8-K | medp-20260421.htm iXBRL | 8-K
2 | EX-99.1 | medp-20260422exx991.htm | EX-99.1
6 | medpace-logoxonxwhitea.jpg | GRAPHIC | 10438
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | medp-20260421.xsd | EX-101.SCH